| Year |
Citation |
Score |
| 2022 |
Haltom AR, Hassen WE, Hensel J, Kim J, Sugimoto H, Li B, McAndrews KM, Conner MR, Kirtley ML, Luo X, Xie B, Volpert OV, Olalekan S, Maltsev N, Basu A, et al. Engineered exosomes targeting MYC reverse the proneural-mesenchymal transition and extend survival of glioblastoma. Extracellular Vesicle. 1. PMID 37503329 DOI: 10.1016/j.vesic.2022.100014 |
0.341 |
|
| 2019 |
Sheibani N, Wang S, Darjatmoko SR, Fisk DL, Shahi PK, Patnaik BR, Sorenson CM, Bhowmick R, Volpert OV, Albert DM, Melgar-Asensio I, Henkin J. Novel anti-angiogenic PEDF-Derived small peptides mitigate, choroidal neovascularization. Experimental Eye Research. 107798. PMID 31520600 DOI: 10.1016/J.Exer.2019.107798 |
0.319 |
|
| 2017 |
Plebanek MP, Angeloni NL, Vinokour E, Li J, Henkin A, Martinez-Marin D, Filleur S, Bhowmick R, Henkin J, Miller SD, Ifergan I, Lee Y, Osman I, Thaxton CS, Volpert OV. Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche. Nature Communications. 8: 1319. PMID 29105655 DOI: 10.1038/S41467-017-01433-3 |
0.302 |
|
| 2017 |
Michael IP, Orebrand M, Lima M, Pereira B, Volpert O, Quaggin SE, Jeansson M. Angiopoietin-1 deficiency increases tumor metastasis in mice. Bmc Cancer. 17: 539. PMID 28800750 DOI: 10.1186/S12885-017-3531-Y |
0.424 |
|
| 2017 |
Martinez-Marin D, Jarvis C, Nelius T, de Riese W, Volpert OV, Filleur S. PEDF increases the tumoricidal activity of macrophages towards prostate cancer cells in vitro. Plos One. 12: e0174968. PMID 28403150 DOI: 10.1371/Journal.Pone.0174968 |
0.447 |
|
| 2016 |
Park JK, Peng H, Yang W, Katsnelson J, Volpert O, Lavker RM. miR-184 exhibits angiostatic properties via regulation of Akt and VEGF signaling pathways. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 27825105 DOI: 10.1096/Fj.201600746R |
0.343 |
|
| 2016 |
Nwani NG, Deguiz ML, Jimenez B, Vinokour E, Dubrovskyi O, Ugolkov A, Mazar AP, Volpert OV. Melanoma Cells Block PEDF Production in Fibroblasts to Induce the Tumor-Promoting Phenotype of Cancer-Associated Fibroblasts. Cancer Research. 76: 2265-76. PMID 26921338 DOI: 10.1158/0008-5472.Can-15-2468 |
0.513 |
|
| 2016 |
Bridgeman BB, Wang P, Ye B, Pelling JC, Volpert OV, Tong X. Inhibition of mTOR by apigenin in UVB-irradiated keratinocytes: A new implication of skin cancer prevention. Cellular Signalling. PMID 26876613 DOI: 10.1016/J.Cellsig.2016.02.008 |
0.397 |
|
| 2015 |
Martinez-Marin D, Nelius T, Volpert O, Filleur S. Abstract 3359: PEDF modulatory action on macrophages: A new way to curb prostate cancer development Cancer Research. 75: 3359-3359. DOI: 10.1158/1538-7445.Am2015-3359 |
0.498 |
|
| 2014 |
Tong X, Mirzoeva S, Veliceasa D, Bridgeman BB, Fitchev P, Cornwell ML, Crawford SE, Pelling JC, Volpert OV. Chemopreventive apigenin controls UVB-induced cutaneous proliferation and angiogenesis through HuR and thrombospondin-1. Oncotarget. 5: 11413-27. PMID 25526033 DOI: 10.18632/Oncotarget.2551 |
0.365 |
|
| 2014 |
Tripathy S, Vinokour E, McMahon KM, Volpert OV, Thaxton CS. High Density Lipoprotein Nanoparticles Deliver RNAi to Endothelial Cells to Inhibit Angiogenesis. Particle & Particle Systems Characterization : Measurement and Description of Particle Properties and Behavior in Powders and Other Disperse Systems. 31: 1141-1150. PMID 25400330 DOI: 10.1002/Ppsc.201400036 |
0.4 |
|
| 2014 |
Gómez-Maldonado L, Tiana M, Roche O, Prado-Cabrero A, Jensen L, Fernandez-Barral A, Guijarro-Muñoz I, Favaro E, Moreno-Bueno G, Sanz L, Aragones J, Harris A, Volpert O, Jimenez B, Del Peso L. EFNA3 long noncoding RNAs induced by hypoxia promote metastatic dissemination Oncogene. 34: 2609-2620. PMID 25023702 DOI: 10.1038/Onc.2014.200 |
0.426 |
|
| 2013 |
Williams LV, Veliceasa D, Vinokour E, Volpert OV. miR-200b inhibits prostate cancer EMT, growth and metastasis. Plos One. 8: e83991. PMID 24391862 DOI: 10.1371/Journal.Pone.0083991 |
0.729 |
|
| 2013 |
Craword SE, Fitchev P, Veliceasa D, Volpert OV. The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder? Expert Opinion On Drug Discovery. 8: 769-92. PMID 23642051 DOI: 10.1517/17460441.2013.794781 |
0.33 |
|
| 2013 |
Tong X, Bridgeman BB, Mirzoeva S, Crawford SE, Volpert OV, Pelling JC. Abstract 5075: Targeting TSP1 and inhibiting angiogenesis in UV-induced skin cancer by apigenin. Cancer Research. 73: 5075-5075. DOI: 10.1158/1538-7445.Am2013-5075 |
0.419 |
|
| 2012 |
Rines AK, Burke MA, Fernandez RP, Volpert OV, Ardehali H. Snf1-related kinase inhibits colon cancer cell proliferation through calcyclin-binding protein-dependent reduction of β-catenin. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 4685-95. PMID 22874833 DOI: 10.1096/Fj.12-212282 |
0.375 |
|
| 2012 |
Mirochnik Y, Veliceasa D, Williams L, Maxwell K, Yemelyanov A, Budunova I, Volpert OV. Androgen receptor drives cellular senescence. Plos One. 7: e31052. PMID 22403609 DOI: 10.1371/Journal.Pone.0031052 |
0.741 |
|
| 2012 |
Biyashev D, Veliceasa D, Topczewski J, Topczewska JM, Mizgirev I, Vinokour E, Reddi AL, Licht JD, Revskoy SY, Volpert OV. miR-27b controls venous specification and tip cell fate. Blood. 119: 2679-87. PMID 22207734 DOI: 10.1182/Blood-2011-07-370635 |
0.337 |
|
| 2011 |
Henkin J, Volpert OV. Therapies using anti-angiogenic peptide mimetics of thrombospondin-1. Expert Opinion On Therapeutic Targets. 15: 1369-86. PMID 22136063 DOI: 10.1517/14728222.2011.640319 |
0.325 |
|
| 2011 |
Sundaram P, Hultine S, Smith LM, Dews M, Fox JL, Biyashev D, Schelter JM, Huang Q, Cleary MA, Volpert OV, Thomas-Tikhonenko A. p53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancers. Cancer Research. 71: 7490-501. PMID 22028325 DOI: 10.1158/0008-5472.Can-11-1124 |
0.343 |
|
| 2011 |
Ladhani O, Sánchez-Martinez C, Orgaz JL, Jimenez B, Volpert OV. Pigment epithelium-derived factor blocks tumor extravasation by suppressing amoeboid morphology and mesenchymal proteolysis. Neoplasia (New York, N.Y.). 13: 633-42. PMID 21750657 DOI: 10.1593/Neo.11446 |
0.743 |
|
| 2011 |
Orgaz JL, Benguria A, Sanchez-Martinez C, Ladhani O, Volpert OV, Jimenez B. Changes in the gene expression profile of A375 human melanoma cells induced by overexpression of multifunctional pigment epithelium-derived factor. Melanoma Research. 21: 285-97. PMID 21673604 DOI: 10.1097/Cmr.0B013E32834495C3 |
0.757 |
|
| 2011 |
Prema S, Hultine S, Smith L, Biyashev D, Schelter J, Cleary M, Volpert O, Thomas-Tikhonenko A. Abstract 3275: miR-194 counterbalances transcriptional activation of the anti-angiogenic factor thrombospondin-1 by p53 Cancer Research. 71: 3275-3275. DOI: 10.1158/1538-7445.Am2011-3275 |
0.329 |
|
| 2010 |
Renault MA, Roncalli J, Tongers J, Thorne T, Klyachko E, Misener S, Volpert OV, Mehta S, Burg A, Luedemann C, Qin G, Kishore R, Losordo DW. Sonic hedgehog induces angiogenesis via Rho kinase-dependent signaling in endothelial cells. Journal of Molecular and Cellular Cardiology. 49: 490-8. PMID 20478312 DOI: 10.1016/J.Yjmcc.2010.05.003 |
0.44 |
|
| 2010 |
Aurora AB, Aurora AB, Biyashev D, Mirochnik Y, Zaichuk TA, Sánchez-Martinez C, Renault MA, Losordo D, Volpert OV. NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement. Blood. 116: 475-84. PMID 20203265 DOI: 10.1182/Blood-2009-07-232132 |
0.325 |
|
| 2010 |
Biyashev D, Veliceasa D, Kwiatek A, Sutanto MM, Cohen RN, Volpert OV. Natural angiogenesis inhibitor signals through Erk5 activation of peroxisome proliferator-activated receptor γ(PPARγ) Journal of Biological Chemistry. 285: 13517-13524. PMID 20185831 DOI: 10.1074/Jbc.M110.117374 |
0.404 |
|
| 2009 |
Orgaz JL, Ladhani O, Hoek KS, Fernández-Barral A, Mihic D, Aguilera O, Seftor EA, Bernad A, Rodríguez-Peralto JL, Hendrix MJ, Volpert OV, Jiménez B. 'Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma'. Oncogene. 28: 4147-61. PMID 19767774 DOI: 10.1038/Onc.2009.284 |
0.755 |
|
| 2009 |
Xiao W, Ai J, Habermacher G, Volpert O, Yang X, Zhang AY, Hahn J, Cai X, Wang Z. U19/Eaf2 binds to and stabilizes von hippel-lindau protein. Cancer Research. 69: 2599-606. PMID 19258512 DOI: 10.1158/0008-5472.Can-08-2595 |
0.345 |
|
| 2009 |
Mirochnik Y, Aurora A, Schulze-Hoepfner FT, Deabes A, Shifrin V, Beckmann R, Polsky C, Volpert OV. Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growth. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1655-63. PMID 19223494 DOI: 10.1158/1078-0432.Ccr-08-2113 |
0.433 |
|
| 2009 |
Okotie OT, Pazona JF, Volpert OV, Kozlowski J, Thaxton CS, Navai N, Helfand BT, Zhao LC, Adley B, Lu Y, Smith ND. NEUROLIGIN 4 ISOFORM Y: A NOVEL MARKER FOR PROSTATE CANCER The Journal of Urology. 181: 657-658. DOI: 10.1016/S0022-5347(09)61844-9 |
0.333 |
|
| 2009 |
Maxwell KM, Mirochnik Y, Williams LV, Volpert OV. IDENTIFICATION OF AR TARGETS CRITICAL FOR TUMOR SENESCENCE Journal of Urology. 181: 94-94. DOI: 10.1016/S0022-5347(09)60267-6 |
0.726 |
|
| 2008 |
Veliceasa D, Schulze-Hoëpfner FT, Volpert OV. PPARgamma and Agonists against Cancer: Rational Design of Complementation Treatments. Ppar Research. 2008: 945275. PMID 19043603 DOI: 10.1155/2008/945275 |
0.409 |
|
| 2008 |
Smith ND, Schulze-Hoepfner FT, Veliceasa D, Filleur S, Shareef S, Huang L, Huang XM, Volpert OV. Pigment epithelium-derived factor and interleukin-6 control prostate neuroendocrine differentiation via feed-forward mechanism. The Journal of Urology. 179: 2427-34. PMID 18433784 DOI: 10.1016/J.Juro.2008.01.081 |
0.379 |
|
| 2008 |
Mirochnik Y, Maxwell KM, Deabes A, Veliceasa D, Williams LV, Schulze-Hoepfner FT, Volpert OV. IDENTIFYING MECHANISMS OF SENESCENCE IN PROSTATE CANCER Journal of Urology. 179: 102-102. DOI: 10.1016/S0022-5347(08)60297-9 |
0.705 |
|
| 2007 |
Veliceasa D, Ivanovic M, Hoepfner FT, Thumbikat P, Volpert OV, Smith ND. Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma. The Febs Journal. 274: 6365-77. PMID 18021253 DOI: 10.1111/J.1742-4658.2007.06159.X |
0.374 |
|
| 2007 |
Nelius T, Filleur S, Yemelyanov A, Budunova I, Shroff E, Mirochnik Y, Aurora A, Veliceasa D, Xiao W, Wang Z, Volpert OV. Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo. International Journal of Cancer. 121: 999-1008. PMID 17487836 DOI: 10.1002/Ijc.22802 |
0.49 |
|
| 2007 |
Filleur T, Volz K, Nelius T, De Riese W, Volpert O. 434 TWO FUNCTIONAL EPITOPES OF PEDF BLOCK ANGIOGENESIS AND INDUCE DIFFERENTIATION IN PROSTATE CANCER European Urology Supplements. 6: 131. DOI: 10.1016/S1569-9056(07)60432-1 |
0.367 |
|
| 2007 |
Nelius T, Filleur S, Shroff E, Mirochnik Y, de Riese W, Volpert O. 269: The Pro-Apoptotic and Anti-Angiogenic Effects of Androgen in the in vivo Model of Prostate Cancer Journal of Urology. 177: 90-90. DOI: 10.1016/S1569-9056(07)60092-X |
0.36 |
|
| 2006 |
Fernandez-Garcia NI, Volpert OV, Jimenez B. Pigment epithelium-derived factor as a multifunctional antitumor factor. Journal of Molecular Medicine (Berlin, Germany). 85: 15-22. PMID 17106733 DOI: 10.1007/S00109-006-0111-Z |
0.433 |
|
| 2006 |
Nelius T, Filleur S, Yap R, Reiher F, Allhoff EP, Volpert O. 440: Blocking of Angiogenesis and Lymphangiogenesis by Doxorubicin and a Truncated TSP1 Peptide Inhibits Prostate Cancer Growth The Journal of Urology. 175: 143-143. DOI: 10.1016/S0022-5347(18)32696-X |
0.375 |
|
| 2005 |
Levenson AS, Thurn KE, Simons LA, Veliceasa D, Jarrett J, Osipo C, Jordan VC, Volpert OV, Satcher RL, Gartenhaus RB. MCT-1 oncogene contributes to increased in vivo tumorigenicity of MCF7 cells by promotion of angiogenesis and inhibition of apoptosis. Cancer Research. 65: 10651-6. PMID 16322206 DOI: 10.1158/0008-5472.Can-05-0845 |
0.49 |
|
| 2005 |
Yap R, Veliceasa D, Emmenegger U, Kerbel RS, McKay LM, Henkin J, Volpert OV. Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: A complementation antiangiogenic strategy Clinical Cancer Research. 11: 6678-6685. PMID 16166447 DOI: 10.1158/1078-0432.Ccr-05-0621 |
0.389 |
|
| 2005 |
Fernandez-Garcia NI, Palmer HG, Garcia M, Gonzalez-Martin A, del Rio M, Barettino D, Volpert O, Muñoz A, Jimenez B. 1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells. Oncogene. 24: 6533-44. PMID 16007183 DOI: 10.1038/Sj.Onc.1208801 |
0.326 |
|
| 2005 |
Filleur S, Volz K, Nelius T, Mirochnik Y, Huang H, Zaichuk TA, Aymerich MS, Becerra SP, Yap R, Veliceasa D, Shroff EH, Volpert OV. Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer Cancer Research. 65: 5144-5152. PMID 15958558 DOI: 10.1158/0008-5472.Can-04-3744 |
0.458 |
|
| 2005 |
Quesada AJ, Nelius T, Yap R, Zaichuk TA, Alfranca A, Filleur S, Volpert OV, Redondo JM. In vivo upregulation of CD95 and CD95L causes synergistic inhibition of angiogenesis by TSP1 peptide and metronomic doxorubicin treatment. Cell Death and Differentiation. 12: 649-58. PMID 15818399 DOI: 10.1038/Sj.Cdd.4401615 |
0.348 |
|
| 2005 |
Apte RS, Barreiro RA, Duh E, Volpert O, Ferguson TA. Stimulation of neovascularization by the anti-angiogenic factor PEDF. Investigative Ophthalmology & Visual Science. 45: 4491-7. PMID 15557459 DOI: 10.1167/Iovs.04-0172 |
0.304 |
|
| 2004 |
Huang H, Campbell SC, Nelius T, Bedford DF, Veliceasa D, Bouck NP, Volpert OV. Alpha1-antitrypsin inhibits angiogenesis and tumor growth. International Journal of Cancer. 112: 1042-8. PMID 15316942 DOI: 10.1002/Ijc.20494 |
0.444 |
|
| 2004 |
Garcia M, Fernandez-Garcia NI, Rivas V, Carretero M, Escamez MJ, Gonzalez-Martin A, Medrano EE, Volpert O, Jorcano JL, Jimenez B, Larcher F, Del Rio M. Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor. Cancer Research. 64: 5632-42. PMID 15313901 DOI: 10.1158/0008-5472.Can-04-0230 |
0.474 |
|
| 2004 |
Zaichuk TA, Shroff EH, Emmanuel R, Filleur S, Nelius T, Volpert OV. Nuclear factor of activated T cells balances angiogenesis activation and inhibition. The Journal of Experimental Medicine. 199: 1513-22. PMID 15184502 DOI: 10.1084/Jem.20040474 |
0.417 |
|
| 2004 |
Koch A, Volpert O, Volin M, Woods J, Ruth J, Park C, Amin M. P-selectin, an important mediator of angiogenesis in females: the role of estradiol Arthritis Research & Therapy. 6: 95-95. DOI: 10.1186/Ar1430 |
0.351 |
|
| 2004 |
Nelius T, Quesada AJ, Alfranca A, Yap RL, Zaichuk T, Redondo JM, Volpert OV. 1112: Treatment with Doxorubicin and a Truncated TSP1 Peptide Synergistically Inhibits Tumor Angiogenesis in Prostate Cancer Journal of Urology. 171: 293-293. DOI: 10.1016/S0022-5347(18)38349-6 |
0.42 |
|
| 2003 |
Zhang YW, Su Y, Volpert OV, Vande Woude GF. Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proceedings of the National Academy of Sciences of the United States of America. 100: 12718-23. PMID 14555767 DOI: 10.1073/Pnas.2135113100 |
0.496 |
|
| 2003 |
Amin MA, Volpert OV, Woods JM, Kumar P, Harlow LA, Koch AE. Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circulation Research. 93: 321-9. PMID 12881477 DOI: 10.1161/01.Res.0000087641.56024.Da |
0.379 |
|
| 2003 |
Volpert OV, Alani RM. Wiring the angiogenic switch: Ras, Myc, and Thrombospondin-1. Cancer Cell. 3: 199-200. PMID 12676576 DOI: 10.1016/S1535-6108(03)00056-4 |
0.402 |
|
| 2003 |
Iñiguez MA, Rodríguez A, Volpert OV, Fresno M, Redondo JM. Cyclooxygenase-2: a therapeutic target in angiogenesis. Trends in Molecular Medicine. 9: 73-8. PMID 12615041 DOI: 10.1016/S1471-4914(02)00011-4 |
0.384 |
|
| 2002 |
Chlenski A, Liu S, Crawford SE, Volpert OV, DeVries GH, Evangelista A, Yang Q, Salwen HR, Farrer R, Bray J, Cohn SL. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. Cancer Research. 62: 7357-63. PMID 12499280 |
0.387 |
|
| 2002 |
Volpert OV, Pili R, Sikder HA, Nelius T, Zaichuk T, Morris C, Shiflett CB, Devlin MK, Conant K, Alani RM. Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell. 2: 473-83. PMID 12498716 DOI: 10.1016/S1535-6108(02)00209-X |
0.428 |
|
| 2002 |
Volpert O, Luo W, Liu TJ, Estrera VT, Logothetis C, Lin SH. Inhibition of prostate tumor angiogenesis by the tumor suppressor CEACAM1. The Journal of Biological Chemistry. 277: 35696-702. PMID 12122002 DOI: 10.1074/jbc.M205319200 |
0.444 |
|
| 2002 |
Volpert OV, Zaichuk T, Zhou W, Reiher F, Ferguson TA, Stuart PM, Amin M, Bouck NP. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nature Medicine. 8: 349-57. PMID 11927940 DOI: 10.1038/Nm0402-349 |
0.419 |
|
| 2002 |
Reiher FK, Volpert OV, Jimenez B, Crawford SE, Dinney CP, Henkin J, Haviv F, Bouck NP, Campbell SC. Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics. International Journal of Cancer. 98: 682-9. PMID 11920636 DOI: 10.1002/Ijc.10247 |
0.469 |
|
| 2001 |
Toft DJ, Rosenberg SB, Bergers G, Volpert O, Linzer DI. Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression. Proceedings of the National Academy of Sciences of the United States of America. 98: 13055-9. PMID 11606769 DOI: 10.1073/Pnas.231364798 |
0.445 |
|
| 2001 |
Jiménez B, Volpert OV. Mechanistic insights on the inhibition of tumor angiogenesis. Journal of Molecular Medicine. 78: 663-672. PMID 11434719 DOI: 10.1007/S001090000178 |
0.467 |
|
| 2001 |
Jiménez B, Volpert OV, Reiher F, Chang L, Muñoz A, Karin M, Bouck N. c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1. Oncogene. 20: 3443-8. PMID 11423995 DOI: 10.1038/Sj.Onc.1204464 |
0.343 |
|
| 2001 |
Filleur S, Volpert OV, Degeorges A, Voland C, Reiher F, Clézardin P, Bouck N, Cabon F. In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects. Genes & Development. 15: 1373-82. PMID 11390357 DOI: 10.1101/Gad.193501 |
0.443 |
|
| 2001 |
Hernández GL, Volpert OV, Iñiguez MA, Lorenzo E, Martínez-Martínez S, Grau R, Fresno M, Redondo JM. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. The Journal of Experimental Medicine. 193: 607-20. PMID 11238591 DOI: 10.1084/Jem.193.5.607 |
0.418 |
|
| 2001 |
Volpert OV. Modulation of endothelial cell survival by an inhibitor of angiogenesis thrombospondin-1: a dynamic balance. Cancer Metastasis Reviews. 19: 87-92. PMID 11191069 DOI: 10.1023/A:1026560618302 |
0.384 |
|
| 2000 |
English D, Welch Z, Kovala AT, Harvey K, Volpert OV, Brindley DN, Garcia JGN. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis Faseb Journal. 14: 2255-2265. PMID 11053247 DOI: 10.1096/Fj.00-0134Com |
0.386 |
|
| 2000 |
Schwarte-Waldhoff I, Volpert OV, Bouck NP, Sipos B, Hahn SA, Klein-Scory S, Lüttges J, Klöppel G, Graeven U, Eilert-Micus C, Hintelmann A, Schmiegel W. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis Proceedings of the National Academy of Sciences of the United States of America. 97: 9624-9629. PMID 10944227 DOI: 10.1073/Pnas.97.17.9624 |
0.46 |
|
| 2000 |
Zhang M, Volpert O, Shi YH, Bouck N. Maspin is an angiogenesis inhibitor. Nature Medicine. 6: 196-9. PMID 10655109 DOI: 10.1038/72303 |
0.51 |
|
| 2000 |
Jiménez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, Bouck N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 Nature Medicine. 6: 41-48. PMID 10613822 DOI: 10.1038/71517 |
0.435 |
|
| 2000 |
Schwarte-Waldhoff I, Volpert OV, Bouck NP, Sipos B, Hahn SA, Klein-Scory S, Luettges J, Kloeppel G, Graeven U, Eilert-Micus C, Hintelmann A, Schmiegel W. DPC4/Smad4 mediated tumor suppression in pancreatic cancer cells through suppression of angiogenesis Gastroenterology. 118: A50. DOI: 10.1016/S0016-5085(00)82271-4 |
0.457 |
|
| 1999 |
Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science (New York, N.Y.). 285: 245-8. PMID 10398599 DOI: 10.1126/Science.285.5425.245 |
0.345 |
|
| 1998 |
Vogler WR, Liu J, Volpert O, Ades EW, Bouck N. The anticancer drug edelfosine is a potent inhibitor of neovascularization in vivo. Cancer Investigation. 16: 549-53. PMID 9844614 DOI: 10.3109/07357909809032884 |
0.418 |
|
| 1998 |
Volpert OV, Fong T, Koch AE, Peterson JD, Waltenbaugh C, Tepper RI, Bouck NP. Inhibition of angiogenesis by interleukin 4. The Journal of Experimental Medicine. 188: 1039-46. PMID 9743522 DOI: 10.1084/Jem.188.6.1039 |
0.313 |
|
| 1998 |
Volpert OV, Lawler J, Bouck NP. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1. Proceedings of the National Academy of Sciences of the United States of America. 95: 6343-8. PMID 9600967 DOI: 10.1073/Pnas.95.11.6343 |
0.429 |
|
| 1997 |
Gately S, Twardowski P, Stack MS, Cundiff DL, Grella D, Castellino FJ, Enghild J, Kwaan HC, Lee F, Kramer RA, Volpert O, Bouck N, Soff GA. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proceedings of the National Academy of Sciences of the United States of America. 94: 10868-72. PMID 9380726 DOI: 10.1073/Pnas.94.20.10868 |
0.44 |
|
| 1997 |
Volpert OV, Dameron KM, Bouck N. Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity. Oncogene. 14: 1495-502. PMID 9136993 DOI: 10.1038/Sj.Onc.1200977 |
0.45 |
|
| 1997 |
Kochhar KS, Johnson ME, Volpert O, Iyer AP. Evidence for autocrine basis of transformation in NIH-3T3 cells transfected with met/HGF receptor gene. Growth Factors (Chur, Switzerland). 12: 303-13. PMID 8930021 DOI: 10.3109/08977199509028968 |
0.375 |
|
| 1996 |
Volpert O, Jackson D, Bouck N, Linzer DI. The insulin-like growth factor II/mannose 6-phosphate receptor is required for proliferin-induced angiogenesis. Endocrinology. 137: 3871-6. PMID 8756559 DOI: 10.1210/Endo.137.9.8756559 |
0.318 |
|
| 1996 |
Volpert OV, Ward WF, Lingen MW, Chesler L, Solt DB, Johnson MD, Molteni A, Polverini PJ, Bouck NP. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats Journal of Clinical Investigation. 98: 671-679. PMID 8698858 DOI: 10.1172/Jci118838 |
0.404 |
|
| 1996 |
Volpert OV, Stellmach V, Bouck N. The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression. Breast Cancer Research and Treatment. 36: 119-26. PMID 8534861 DOI: 10.1007/Bf00666034 |
0.49 |
|
| 1996 |
Volpert OV, Tolsma SS, Pellerin S, Feige JJ, Chen H, Mosher DF, Bouck N. Inhibition of angiogenesis by thrombospondin-2. Biochemical and Biophysical Research Communications. 217: 326-32. PMID 8526929 DOI: 10.1006/Bbrc.1995.2780 |
0.399 |
|
| 1995 |
Jackson D, Volpert OV, Bouck N, Linzer DI. Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein. Science (New York, N.Y.). 266: 1581-4. PMID 7527157 DOI: 10.1126/Science.7527157 |
0.37 |
|
| 1994 |
Dameron KM, Volpert OV, Tainsky MA, Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1 Science. 265: 1582-1584. PMID 7521539 DOI: 10.1126/Science.7521539 |
0.41 |
|
| 1993 |
Benton BK, Volpert OV, Bouck NP. Influence of a hamster tumor suppressor gene on transformation by viral and cellular oncogenes Carcinogenesis. 14: 1209-1214. PMID 8389673 DOI: 10.1093/Carcin/14.6.1209 |
0.319 |
|
| 1993 |
Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. The Journal of Cell Biology. 122: 497-511. PMID 7686555 DOI: 10.1083/Jcb.122.2.497 |
0.364 |
|
| Show low-probability matches. |